We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Berkshire Hathaway Class B
BRK.B
$1.07T
| $17.9M | 0.42% |
69,935
-3,946
| -5% | -$958K |
|
52
Costco
COST
$415B
| $17.8M | 0.42% |
50,587
+8,031
| +19% | +$2.8M |
|
53
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
| $17.8M | 0.42% |
559,159
+6,219
| +1% | +$203K |
|
54
Chubb
CB
$140B
| $17.3M | 0.41% |
109,246
+60,496
| +124% | +$9.75M |
|
55
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $16.7M | 0.4% |
340,607
-1,624
| -0.5% | -$79.3K |
|
56
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
| $16.2M | 0.39% |
491,436
+8,534
| +2% | +$280K |
|
57
Netflix
NFLX
$292B
| $16.2M | 0.39% |
311,150
+243,000
| +357% | +$12.9M |
|
58
Broadcom
AVGO
$1.82T
| $15.8M | 0.37% |
340,260
+244,620
| +256% | +$11.3M |
|
59
Salesforce
CRM
$134B
| $15.1M | 0.36% |
71,206
-18,707
| -21% | -$4.16M |
|
60
NextEra Energy
NEE
$187B
| $15M | 0.36% |
198,456
+121,522
| +158% | +$9.48M |
|
61
Paychex
PAYX
$40.4B
| $14.5M | 0.35% |
148,320
-387
| -0.3% | -$35.6K |
|
62
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $14.2M | 0.34% |
525,688
-802
| -0.2% | -$22K |
|
63
Allogene Therapeutics
ALLO
$601M
| $14.2M | 0.34% |
+401,602
| New | +$13.5M |
|
64
Invesco QQQ Trust
QQQ
$455B
| $14.1M | 0.33% |
44,140
+14,856
| +51% | +$4.75M |
|
65
American Tower
AMT
$77.7B
| $14M | 0.33% |
58,638
+12,353
| +27% | +$2.75M |
|
66
Generac Holdings
GNRC
$11.9B
| $13.9M | 0.33% |
42,384
-6,171
| -13% | -$1.82M |
|
67
Jacobs Solutions
J
$15.9B
| $13.7M | 0.33% |
+128,043
| New | +$12.2M |
|
68
iShares S&P 100 ETF
OEF
$19.8B
| $13.2M | 0.31% |
73,540
+63,364
| +623% | +$11.2M |
|
69
Teladoc Health
TDOC
$1.58B
| $13.1M | 0.31% |
71,894
+68,133
| +1,812% | +$15.8M |
|
70
Estee Lauder
EL
$29B
| $12.7M | 0.3% |
43,530
-258
| -0.6% | -$70.6K |
|
71
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
| $12.5M | 0.3% |
186,561
+11,005
| +6% | +$753K |
|
72
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
| $12.3M | 0.29% |
+100,803
| New | +$11.9M |
|
73
Vanguard Real Estate ETF
VNQ
$39.9B
| $12.3M | 0.29% |
133,527
+2,589
| +2% | +$228K |
|
|
ANSS
74
DELISTED
Ansys
ANSS
| $11.8M | 0.28% |
34,663
+28,929
| +505% | +$10.3M |
|
75
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $11.6M | 0.28% |
89,370
+37,282
| +72% | +$4.96M |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.